{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T19:41:03Z","timestamp":1783539663353,"version":"3.55.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T00:00:00Z","timestamp":1577750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Catherine McEwan Foundation"},{"name":"NHS Research Scotland Senior"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,6,19]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Increased risk of opportunistic infection\u2014e.g., varicella zoster infection\u2014secondary to therapies is a cause of morbidity in inflammatory bowel disease [IBD] patients. The UK vaccination schedule does not include varicella immunisation. We aimed to evaluate the varicella screening and immunisation programme in a paediatric IBD population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Data regarding IBD diagnosis, varicella status, and consequent immunisations\/treatment interventions were collected retrospectively from the records of patients diagnosed with IBD over a 10-year period [2009\u20132018].<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In all, 520 IBD patients were diagnosed; 505\/520 [97%] had varicella testing; 46\/505 [9%] were na\u00efve. Of 501 patients, 391[78%] were tested before or within 7 days of diagnosis; this increased in the second 5-year period compared with the first (229\/268 [85%] versus 162\/233 [70%]; p\u2005&amp;lt;0.00001). Median diagnosis age of na\u00efve patients was lower [8.3 years versus 12.8 years; p\u2005&amp;lt;0.00001]. Where vaccination was feasible, 21\/31 [68%] had two and 7\/31 [23%] one immunisation. Prednisolone induction led to lower rates of vaccination (5\/13 [39%] versus 23\/33 [70%] for other induction therapies; p\u2005=0.02). Of 28 vaccinated patients, 5 [18%] had suspected breakthrough varicella; and 6\/18 [33%] unimmunised patients required post-exposure prophylaxis or treatment for varicella. Immunisation was associated with a decrease in patients requiring post-exposure prophylaxis (0\/28 [0%] versus 5\/18 [28%]; p\u2005=0.0006) and varicella-related hospital admission (1\/28 [4%] versus 4\/18 [22%]; p\u2005=0.01).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>High rates of varicella screening and immunisation within a PIBD population are possible, resulting in a reduction in hospital admissions for varicella treatment. Varicella immunisation may be of increasing importance within the PIBD population with the emergence of novel therapeutic strategies.<\/jats:p><\/jats:sec>","DOI":"10.1093\/ecco-jcc\/jjz207","type":"journal-article","created":{"date-parts":[[2019,12,30]],"date-time":"2019-12-30T20:11:13Z","timestamp":1577736673000},"page":"608-616","source":"Crossref","is-referenced-by-count":4,"title":["A Decade of Varicella Screening Within a Paediatric Inflammatory Bowel Disease Population"],"prefix":"10.1093","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6507-3487","authenticated-orcid":false,"given":"Rachel E","family":"Harris","sequence":"first","affiliation":[{"name":"Department of Paediatric Gastroenterology, Hepatology and Nutrition, Royal Hospital for Children, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Curtis","sequence":"first","affiliation":[{"name":"Department of Paediatric Gastroenterology, Hepatology and Nutrition, Royal Hospital for Children, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Hegde","sequence":"first","affiliation":[{"name":"School of Medicine, University of Glasgow, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikki","family":"Garrick","sequence":"first","affiliation":[{"name":"Department of Paediatric Gastroenterology, Hepatology and Nutrition, Royal Hospital for Children, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Gervais","sequence":"first","affiliation":[{"name":"Department of Paediatric Gastroenterology, Hepatology and Nutrition, Royal Hospital for Children, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Armstrong","sequence":"first","affiliation":[{"name":"Department of Paediatrics, University Hospital Crosshouse, Crosshouse, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Delahunty","sequence":"first","affiliation":[{"name":"Department of Paediatrics, Wishaw General Hospital, Wishaw, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Eccleston","sequence":"first","affiliation":[{"name":"Department of Paediatrics, Dumfries and Galloway Royal Infirmary, Dumfries, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghassan","family":"Al-Hourani","sequence":"first","affiliation":[{"name":"Department of Paediatrics, Forth Valley Royal Hospital, Larbert, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana M","family":"Flynn","sequence":"first","affiliation":[{"name":"Department of Paediatric Gastroenterology, Hepatology and Nutrition, Royal Hospital for Children, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Merrick","sequence":"first","affiliation":[{"name":"Department of Paediatric Gastroenterology, Hepatology and Nutrition, Royal Hospital for Children, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R","family":"Barclay","sequence":"first","affiliation":[{"name":"Department of Paediatric Gastroenterology, Hepatology and Nutrition, Royal Hospital for Children, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Tayler","sequence":"first","affiliation":[{"name":"Department of Paediatric Gastroenterology, Hepatology and Nutrition, Royal Hospital for Children, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Hansen","sequence":"first","affiliation":[{"name":"Department of Paediatric Gastroenterology, Hepatology and Nutrition, Royal Hospital for Children, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard K","family":"Russell","sequence":"first","affiliation":[{"name":"Department of Paediatric Gastroenterology, Hepatology and Nutrition, Royal Hospital for Children, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,12,31]]},"reference":[{"key":"2020061904033848100_CIT0001","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/apt.15297","article-title":"Systematic review with meta-analysis: efficacy and safety of oral Janus kinase inhibitors for inflammatory bowel disease","volume":"50","author":"Ma","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"2020061904033848100_CIT0002","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1053\/j.gastro.2008.01.012","article-title":"Risk factors for opportunistic infections in patients with inflammatory bowel disease","volume":"134","author":"Toruner","year":"2008","journal-title":"Gastroenterology"},{"key":"2020061904033848100_CIT0003","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1128\/CMR.9.3.361","article-title":"Varicella-zoster virus","volume":"9","author":"Arvin","year":"1996","journal-title":"Clin Microbiol Rev"},{"key":"2020061904033848100_CIT0004","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1056\/NEJMp1905099","article-title":"Measles in 2019","volume":"380","author":"Paules","year":"2019","journal-title":"N Engl J Med"},{"key":"2020061904033848100_CIT0005","doi-asserted-by":"crossref","first-page":"l634","DOI":"10.1136\/bmj.l634","article-title":"Measles cases in Europe tripled from 2017 to 2018","volume":"364","author":"Thornton","year":"2019","journal-title":"BMJ"},{"key":"2020061904033848100_CIT0006","author":"Vaccine Scheduler","year":"2019."},{"key":"2020061904033848100_CIT0007","first-page":"1","article-title":"Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices [ACIP]","volume":"56","author":"Marin","year":"2007","journal-title":"MMWR Recomm Rep"},{"key":"2020061904033848100_CIT0008","doi-asserted-by":"crossref","first-page":"e20153741","DOI":"10.1542\/peds.2015-3741","article-title":"Global varicella vaccine effectiveness: a meta-analysis","volume":"137","author":"Marin","year":"2016","journal-title":"Pediatrics"},{"key":"2020061904033848100_CIT0009","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.crohns.2013.12.013","article-title":"Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease","volume":"8","author":"Rahier","year":"2014","journal-title":"J Crohns Colitis"},{"key":"2020061904033848100_CIT0010","doi-asserted-by":"crossref","DOI":"10.1093\/ibd\/izz106","article-title":"Prudence using serology to determine vaccine-induced immunity to measles and varicella in patients with inflammatory bowel disease","author":"Caldera","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"2020061904033848100_CIT0011","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/MPG.0000000000000239","article-title":"ESPGHAN revised Porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents","volume":"58","author":"Levine","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2020061904033848100_CIT0012","author":"Guidance for Issuing Varicella-zoster Immunoglobulin [VZIG].","year":"2017."},{"key":"2020061904033848100_CIT0013","author":"Varicella-Zoster Vaccine","year":"2019"},{"key":"2020061904033848100_CIT0014","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/MPG.0b013e31821e1917","article-title":"Varicella immunity in inflammatory bowel disease","volume":"53","author":"Ansari","year":"2011","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2020061904033848100_CIT0015","doi-asserted-by":"crossref","first-page":"4139656","DOI":"10.1155\/2017\/4139656","article-title":"Serology of viral infections and tuberculosis screening in an IBD population referred to a tertiary centre of Southern Italy","volume":"2017","author":"Ardesia","year":"2017","journal-title":"Gastroenterol Res Pract"},{"key":"2020061904033848100_CIT0016","doi-asserted-by":"crossref","first-page":"e449","DOI":"10.1016\/j.crohns.2013.02.019","article-title":"Implementing guidelines on the prevention of opportunistic infections in inflammatory bowel disease","volume":"7","author":"Walsh","year":"2013","journal-title":"J Crohns Colitis"},{"key":"2020061904033848100_CIT0017","first-page":"604","article-title":"Varicella vaccine [VARIVAX] in healthy children and adolescents: results from clinical trials, 1987 to 1989","volume":"87","author":"White","year":"1991","journal-title":"Pediatrics"},{"key":"2020061904033848100_CIT0018","author":"Varicella Vaccination in the European Union.","year":"2015."},{"key":"2020061904033848100_CIT0019","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1086\/522124","article-title":"Lack of association between age at varicella vaccination and risk of breakthrough varicella, within the Northern California Kaiser Permanente Medical Care Program","volume":"197","author":"Black","year":"2008","journal-title":"J Infect Dis"},{"key":"2020061904033848100_CIT0020","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1093\/ibd\/izy150","article-title":"Herpes zoster in patients receiving JAK inhibitors for ulcerative colitis: mechanism, epidemiology, management, and prevention","volume":"24","author":"Colombel","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"2020061904033848100_CIT0021","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1093\/ibd\/izy131","article-title":"Herpes zoster infection in patients with ulcerative colitis receiving tofacitinib","volume":"24","author":"Winthrop","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"2020061904033848100_CIT0022","doi-asserted-by":"crossref","first-page":"ofw205","DOI":"10.1093\/ofid\/ofw205","article-title":"Risk of Herpes zoster in individuals on biologics, disease-modifying antirheumatic drugs, and\/or corticosteroids for autoimmune diseases: a systematic review and meta-analysis","volume":"3","author":"Marra","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"2020061904033848100_CIT0023","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1002\/art.40189","article-title":"Herpes Zoster and tofacitinib: clinical outcomes and the risk of concomitant therapy","volume":"69","author":"Winthrop","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2020061904033848100_CIT0024","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12969-017-0212-y","article-title":"Pharmacokinetic and safety profile of tofacitinib in children with polyarticular course juvenile idiopathic arthritis: results of a phase 1, open-label, multicenter study","volume":"15","author":"Ruperto","year":"2017","journal-title":"Pediatr Rheumatol Online J"},{"key":"2020061904033848100_CIT0025","first-page":"1","article-title":"Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices [ACIP]","volume":"57","author":"Harpaz","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"2020061904033848100_CIT0026","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/apt.14257","article-title":"Safety of herpes zoster vaccination among inflammatory bowel disease patients being treated with anti-TNF medications","volume":"46","author":"Khan","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"2020061904033848100_CIT0027","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12969-018-0231-3","article-title":"Varicella-zoster-virus vaccination in immunosuppressed children with rheumatic diseases using a pre-vaccination check list","volume":"16","author":"Speth","year":"2018","journal-title":"Pediatr Rheumatol Online J"},{"key":"2020061904033848100_CIT0028","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1097\/MIB.0000000000000743","article-title":"Herpes Zoster vaccine response in inflammatory bowel disease patients on low-dose immunosuppression","volume":"22","author":"Wasan","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"2020061904033848100_CIT0029","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","article-title":"Efficacy of the Herpes zoster subunit vaccine in adults 70 years of age or older","volume":"375","author":"Cunningham","year":"2016","journal-title":"N Engl J Med"},{"key":"2020061904033848100_CIT0030","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"N Engl J Med"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/advance-article-pdf\/doi\/10.1093\/ecco-jcc\/jjz207\/31911458\/jjz207.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/14\/5\/608\/33406166\/jjz207.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/14\/5\/608\/33406166\/jjz207.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,9]],"date-time":"2022-10-09T14:53:15Z","timestamp":1665327195000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article\/14\/5\/608\/5691246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,31]]},"references-count":30,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,12,31]]},"published-print":{"date-parts":[[2020,6,19]]}},"URL":"https:\/\/doi.org\/10.1093\/ecco-jcc\/jjz207","relation":{},"ISSN":["1873-9946","1876-4479"],"issn-type":[{"value":"1873-9946","type":"print"},{"value":"1876-4479","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,5]]},"published":{"date-parts":[[2019,12,31]]}}}